| Nov 8 |
A stronger Ozempic, Wegovy sales boom, and Hims' generic weight loss drug: Pharma news roundup
|
| Nov 7 |
Compounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware
|
| Nov 7 |
Novo Nordisk Reports Strong Sales Growth in 2024
|
| Nov 7 |
Novo shares hits 9-month low as 2025 guidance underwhelms
|
| Nov 7 |
Novo Nordisk's stock hits 9-month low as 2025 guidance underwhelms
|
| Nov 7 |
Novo Nordisk AS (NVO) Q3 2024 Earnings Call Highlights: Robust Sales Growth and Strategic ...
|
| Nov 6 |
Forecasting The Future: 7 Analyst Projections For Novo Nordisk
|
| Nov 6 |
A new stronger Ozempic is coming. Here's what to know
|
| Nov 6 |
Sector Update: Health Care Stocks Mixed Wednesday Afternoon
|
| Nov 6 |
Novo Nordisk expects high demand for its obesity drugs in India, says country head
|
